Dyne Therapeutics Inc (DYN)
25.13
-0.33
(-1.30%)
USD |
NASDAQ |
Apr 30, 11:51
Dyne Therapeutics Cash from Investing (Quarterly): 26.20M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.20M |
| September 30, 2023 | 12.82M |
| June 30, 2023 | 17.23M |
| March 31, 2023 | 27.06M |
| December 31, 2022 | 19.24M |
| September 30, 2022 | 51.66M |
| June 30, 2022 | 18.44M |
| March 31, 2022 | -2.136M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.235M |
| September 30, 2021 | -2.848M |
| June 30, 2021 | -6.434M |
| March 31, 2021 | -128.38M |
| December 31, 2020 | -45.22M |
| September 30, 2020 | -0.156M |
| June 30, 2020 | -0.071M |
| March 31, 2020 | -0.211M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-128.38M
Minimum
Mar 2021
51.66M
Maximum
Sep 2022
-0.815M
Average
-0.1135M
Median
Cash from Investing (Quarterly) Benchmarks
| Solid Biosciences Inc | 45.30M |
| Sana Biotechnology Inc | 15.31M |
| Tenaya Therapeutics Inc | -14.92M |
| Prime Medicine Inc | 41.28M |
| CEL-SCI Corp | -0.0649M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -35.01M |
| Cash from Financing (Quarterly) | 0.147M |
| Free Cash Flow | -188.89M |
| Free Cash Flow Per Share (Quarterly) | -0.5714 |
| Free Cash Flow Yield | -12.60% |